MeSH

A ticlopidine analog and platelet purinergic P2Y receptor antagonist that inhibits adenosine diphosphate-mediated PLATELET AGGREGATION. It is used to prevent THROMBOEMBOLISM in patients with ARTERIAL OCCLUSIVE DISEASES; MYOCARDIAL INFARCTION; STROKE; or ATRIAL FIBRILLATION.

Year introduced: 2019 (1988)

metabolite of clopidogrel

Date introduced: May 29, 2009

InChIKey: DCASRSISIKYPDD-UHFFFAOYSA-N

Date introduced: May 7, 2008

Platelet inhibitors; structure in first source

Date introduced: April 29, 2008